Not Yet RecruitingNot Applicable

The Benefits of Home Exercise in Pulmonary Hypertension Interstitial Lung Disease

30 participantsStarted 2026-05-30

Plain-language summary

This study evaluates the effects of a structured home exercise program in participants with pulmonary hypertension associated with interstitial lung disease. Participants will complete a defined exercise regimen over a 16-week period, and functional capacity and patient reported outcomes will be assessed at baseline and after the intervention. The study aims to determine whether a home-based exercise approach is feasible and associated with improvements in functional performance.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Follows at University of Rochester Medical Center Pulmonary Hypertension Clinic. * Adult patients (\>18 years old) with right heart catheterization confirmed pulmonary hypertension interstitial lung disease on stable therapy dosing for at least 30 days. * Access to a smart phone or email to receive daily messages. * Clinically stable by the investigator. Exclusion Criteria: * Pregnancy. * Pulmonary Hypertension Groups 1,2,4,5. * Resting tachycardia \>120 beats/m during screening. * Inability to walk. * WHO Functional Class IV * Lack of access to email or text messaging. * Participating in a rehabilitation program.

What they're measuring

Mean Change in Cardiac Effort From Baseline to 16 Weeks

Timeframe: Baseline to 16 weeks

Trial details

NCT IDNCT07561034

SponsorUniversity of Rochester

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2027-05-30

Contact for this trial

Daniel Lachant, DO

585 273 4608 Daniel_Lachant@urmc.rochester.edu

View on ClinicalTrials.gov More Pulmonary Hypertension trials